An annual report is a powerful and revealing document about a company's financial standing, and can offer the savvy reader substantial insight about where the company may be headed in the future. But to the untrained eye, it may seem like walls of accounting technicalities provided to fill up space between the glossy photos and the upbeat "Message from the CEO."Annual Reports 101 gets past the PR machine to show the meaning behind the math. This straightforward guide reveals how to read the primary financial documents in the report, and then extract more information--from the numbers themselves and from the often fluffy text--than some companies want the public to know. The book shows how to watch out for "red flags," decipher footnotes and see past common practices that, while legal, may not give the most accurate picture. Readers of annual reports include potential investors and business partners, financial advisers, company employees, lenders and many others whose stake in the success of a public company is crucial to their own.

Annual Reports in Computational Chemistry provides timely and critical reviews of important topics in computational chemistry as applied to all chemical disciplines. Topics covered include quantum chemistry, molecular mechanics, force fields, chemical education, and applications in academic and industrial settings. Focusing on the most recent literature and advances in the field, each article covers a specific topic of importance to computational chemists. Quantum chemistry Molecular mechanics Force fields Chemical education and applications in academic and industrial settings

Platform Technologies in Drug Discovery and Validation, Volume 50, the latest release in the Annual Reports in Medicinal Chemistry series, provides timely and critical reviews of important topics in medicinal chemistry, with an emphasis on emerging topics in the biological sciences. Topics covered in this new volume include DELT, Oligos: ASO, siRNA, CRISPR, Micro-fluidic chemistry, High throughput screening, Kinase-centric computational drug development, Virtual Screening, Phenotypic screening, PROTACS, Chemical Biology, Fragment-based lead generation, Antibody-Drug Conjugates, Antibody-recruiting small molecules, Deuteration, and Peptides. Unique for its treatment of platform technologies for medicinal chemistry and target validation Provides a single, rich volume that summaries a broad spectrum of expertise relevant to the field Presents state-of-the-art summaries of platform technologies